Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells

Cancer Letters

Volumn 314, Issue 2, 2012, Pages 232-243

  Xu, Ye ^a,b   Yu, Huimei ^a   Qin, Hanjiao ^a   Kang, JinSong ^a   Yu, Chunyan ^c   Zhong, Jiateng ^a   Su, Jing ^a   Li, HongYan ^a   Sun, Lian Kun ^a  

^a Basic Medical College   (China)

^b JILIN MEDICAL COLLEGE   (China)

^c BEIHUA UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; Cervical cancer; Cisplatin; ER stress

Indexed keywords

3 METHYLADENINE; CELL PROTEIN; CHLOROQUINE; CISPLATIN; TUNICAMYCIN; 3-METHYLADENINE; ADENINE; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; DRUG DERIVATIVE; ERN2 PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEIN SERINE THREONINE KINASE; RIBONUCLEASE;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; ENDOPLASMIC RETICULUM STRESS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN UNFOLDING; UBIQUITINATION; UPREGULATION; UTERINE CERVIX CANCER; CELL PROLIFERATION; DRUG EFFECT; FEMALE; HELA CELL; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; UTERINE CERVIX TUMOR;

ADENINE; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL PROLIFERATION; CHLOROQUINE; CISPLATIN; ENDOPLASMIC RETICULUM STRESS; ENDORIBONUCLEASES; FEMALE; HELA CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; PROTEIN-SERINE-THREONINE KINASES; TUNICAMYCIN; UTERINE CERVICAL NEOPLASMS;

EID: 84863087047     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.09.034     Document Type: Article

References (59)

1. P.J. Loehrer, L.H. Einhorn, Drugs five years later: cisplatin, Ann. Int. Med. 100 (5) (1984) 704-713.
2. J. Reedijk, New clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA, Proc. Natl. Acad. Sci. USA 100 (7) (2003) 3611-3616.
3. K. Woźniak, J. Błasiak, Recognition and repair of DNA-cisplatin adducts, Acta Biochim. Pol. 49 (3) (2002) 583-596.
4. A. Basu, S. Krishnamurthy, Cellular responses to cisplatin-induced DNA damage, J. Nucleic Acids 22 (2010) 201367.
5. A. Mandic, J. Hansson, S. Linder, M.C. Shoshan, Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling, J. Biol. Chem. 278 (11) (2003) 9100-9106.
6. F. Yu, J. Megyesi, P.M. Price, Cytoplasmic initiation of cisplatin cytotoxicity, Am. J. Physiol. Renal Physiol. 295 (1) (2008) F44-F52.
7. D.H. Perlmutter, Misfolded proteins in the endoplasmic reticulum, Lab. Invest. 79 (6) (1999) 623-638.
8. R.R. Kopito, D. Ron, Conformational disease, Nat. Cell Biol. 2 (11) (2000) E207-E209.
9. E. Szegezdi, S.E. Logue, A.M. Gorman, A. Samali, Mediators of endoplasmic reticulum stress-induced apoptosis, EMBO Rep. 7 (9) (2006) 880-885.
10. M. Ogata, S. Hino, A. Saito, K. Morikawa, S. Kondo, S. Kanemoto, T. Murakami, M. Taniguchi, I. Tanii, K. Yoshinaga, S. Shiosaka, J.A. Hammarback, F. Urano, K. Imaizumi, Autophagy is activated for cell survival after endoplasmic reticulum stress, Mol. Cell. Biol. 26 (24) (2006) 9220-9231.
11. Y. Kouroku, E. Fujita, I. Tanida, T. Ueno, A. Isoai, H. Kumagai, S. Ogawa, R.J. Kaufman, E. Kominami, T. Momoi, ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation, Cell Death Differ. 14 (2) (2007) 230-239.
12. A. Criollo, M.C. Maiuri, E. Tasdemir, I. Vitale, A.A. Fiebig, D. Andrews, J. Molgó, J. Díaz, S. Lavandero, F. Harper, G. Pierron, D. di Stefano, R. Rizzuto, G. Szabadkai, G. Kroemer, Regulation of autophagy by the inositol trisphosphate receptor, Cell Death Differ. 14 (5) (2007) 1029-1039.
13. P. Boya, R.A. González-Polo, N. Casares, J.L. Perfettini, P. Dessen, N. Larochette, D. Métivier, D. Meley, S. Souquere, T. Yoshimori, G. Pierron, P. Codogno, G. Kroemer, Inhibition of macroautophagy triggers apoptosis, Mol. Cell. Biol. 25 (3) (2005) 1025-1040.
14. M. Katayama, T. Kawaguchi, M.S. Berger, R.O. Pieper, DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells, Cell Death Differ. 14 (3) (2007) 548-558.
15. J.S. Carew, S.T. Nawrocki, J.L. Cleveland, Modulating autophagy for therapeutic benefit, Autophagy 3 (5) (2007) 464-467.
16. W. Zhuang, Z. Qin, Z. Liang, The role of autophagy in sensitizing malignant glioma cells to radiation therapy, Acta Biochim. Biophys. Sin. (Shanghai) 41 (5) (2009) 341-351.
17. K.N. Dalby, I. Tekedereli, G. Lopez-Berestein, B. Ozpolat, Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer, Autophagy 6 (3) (2010) 322-329 (Epub 2010 April 26).
18. S. Daido, T. Kanzawa, A. Yamamoto, H. Takeuchi, Y. Kondo, S. Kondo, Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells, Cancer Res. 64 (12) (2004) 4286-4293.
19. A. Vazquez-Martin, C. Oliveras-Ferraros, J.A. Menendez, Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab, PLoS ONE 4 (7) (2009) e6251.
20. W. Han, L. Li, S. Qiu, Q. Lu, Q. Pan, Y. Gu, J. Luo, X. Hu, Shikonin circumvents cancer drug resistance by induction of a necroptotic death, Mol. Cancer Ther. 6 (5) (2007) 1641-1649.
21. D.J. Klionsky, H. Abeliovich, P. Agostinis, D.K. Agrawal, G. Aliev, D.S. Askew, M. Baba, E.H. Baehrecke, B.A. Bahr, A. Ballabio, B.A. Bamber, et al., Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes, Autophagy 4 (2) (2008) 151-175.
22. M. Koike, M. Shibata, S. Waguri, K. Yoshimura, I. Tanida, E. Kominami, T. Gotow, C. Peters, K. von Figura, N. Mizushima, P. Saftig, Y. Uchiyama, Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroidlipofuscinoses (Batten disease), Am. J. Pathol. 167 (6) (2005) 1713- 1728.
23. F. Muggia, Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer, Gynecol. Oncol. 112 (1) (2009) 275-281.
24. S.E. Sherman, D. Gibson, A.H. Wang, S.J. Lippard, X-ray structure of the major adduct of the anticancer drug cisplatin with DNA: cis-[Pt(NH3)2(d(pGpG))], Science 230 (4724) (1985) 412-417.
25. S.G. Chaney, S.L. Campbell, E. Bassett, Y. Wu, Recognition and processing of cisplatin- and oxaliplatin-DNA adducts, Crit. Rev. Oncol. Hematol. 53 (1) (2005) 3-11.
26. A. Rebillard, D. Lagadic-Gossmann, M.T. Dimanche-Boitrel, Cisplatin cytotoxicity: DNA and plasma membrane targets, Curr. Med. Chem. 15 (26) (2008) 2656-2663.
27. K.J. Cullen, Z. Yang, L. Schumaker, Z. Guo, Mitochondria as a critical target of the chemotherapeutic agent cisplatin in head and neck cancer, J. Bioenerg. Biomembr. 39 (1) (2007) 43-50.
28. H. Zeng, S. Zhang, K.Y. Yang, T. Wang, J.L. Hu, L.L. Huang, G. Wu, Knockdown of second mitochondria-derived activator of caspase expression by RNAi enhances growth and cisplatin resistance of human lung cancer cells, Cancer Biother. Radiopharm. 25 (6) (2010) 705-712.
29. J.L. Podratz, A.M. Knight, L.E. Ta, N.P. Staff, J.M. Gass, K. Genelin, A. Schlattau, L. Lathroum, A.J. Windebank, Cisplatin induced Mitochondrial DNA damage in dorsal root ganglion neurons, Neurobiol. Dis. 41 (3) (2011) 661-668.
30. M. Jiang, C.Y. Wang, S. Huang, T. Yang, Z. Dong, Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway, Am. J. Physiol. Renal Physiol. 296 (5) (2009) F983-F993.
31. J. Zhu, Y. Yang, J. Wu, Bcl-2 cleavages at two adjacent sites by different caspases promote cisplatin-induced apoptosis, Cell Res. 17 (5) (2007) 441-448.
32. H. Sharma, S. Sen, N. Singh, Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer, Cancer Biol. Ther. 4 (9) (2005) 949-955 (Epub 2005 September 9).
33. Q. Wei, G. Dong, J. Franklin, Z. Dong, The pathological role of Bax in cisplatin nephrotoxicity, Kidney Int. 72 (1) (2007) 53-62 (Epub 2007 April 4).
34. M.J. Berridge, The endoplasmic reticulum: a multifunctional signaling organelle, Cell Calcium 32 (5-6) (2002) 235-249.
35. M. Peyrou, P.E. Hanna, A.E. Cribb, Cisplatin, gentamicin, and paminophenol induce markers of endoplasmic reticulum stress in the rat kidneys, Toxicol. Sci. 99 (1) (2007) 346-353 (Epub 2007 June 12).
36. A. Ruiz, C. Matute, E. Alberdi, Intracellular Ca2+ release through ryanodine receptors contributes to AMPA receptor-mediated mitochondrial dysfunction and ER stress in oligodendrocytes, Cell Death Dis. 1 (7) (2010) e54.
37. J.W. Lee, W.H. Kim, J. Yeo, M.H. Jung, ER stress is implicated in mitochondrial dysfunction-induced apoptosis of pancreatic beta cells, Mol Cells. 30 (6) (2010) 545-549 (Epub 2010 December 3).
38. K. Takemoto, S. Miyata, H. Takamura, T. Katayama, M. Tohyama, Mitochondrial TRAP1 regulates the unfolded protein response in the endoplasmic reticulum, Neurochem. Int. (2011) (Epub ahead of print).
39. S. Pattingre, L. Espert, M. Biard-Piechaczyk, P. Codogno, Regulation of macroautophagy by mTOR and Beclin 1 complexes, Biochimie 90 (2) (2008) 313-323 (Epub 2007 September 8).
40. H. Zhang, X. Kong, J. Kang, J. Su, Y. Li, J. Zhong, L. Sun, Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells, Toxicol. Sci. 110 (2) (2009) 376-388 (Epub 2009 May 18).
41. S. Paglin, N.Y. Lee, C. Nakar, M. Fitzgerald, J. Plotkin, B. Deuel, N. Hackett, M. McMahill, E. Sphicas, N. Lampen, J. Yahalom, Rapamycinsensitive pathway regulates mitochondrial membrane potential, autophagy, and survival in irradiated MCF-7 cells, Cancer Res. 65 (23) (2005) 11061-11070.
42. H. Takeuchi, Y. Kondo, K. Fujiwara, T. Kanzawa, H. Aoki, G.B. Mills, S. Kondo, Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors, Cancer Res. 65 (8) (2005) 3336-3346.
43. S. Periyasamy-Thandavan, M. Jiang, et al., Autophagy: molecular machinery, regulation, and implications for renal pathophysiology, Am. J. Physiol. Renal Physiol. 297 (2) (2009) F244-F256.
44. M.M. Kincaid, A.A. Cooper, ERADicate ER stress or die trying, Antioxid. Redox Signal. 9 (12) (2007) 2373-2387.
45. W.X. Ding, H.M. Ni, W. Gao, T. Yoshimori, D.B. Stolz, D. Ron, X.M. Yin, Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability, Am. J. Pathol. 171 (2) (2007) 513-524.
46. Z. Tallóczy, W. Jiang, H.W. Virgin 4th, D.A. Leib, D. Scheuner, R.J. Kaufman, E.L. Eskelinen, B. Levine, Regulation of starvation-and virus-induced autophagy by the eIF2alpha kinase signaling pathway, Proc. Natl. Acad. Sci. USA 99 (1) (2002) 190-195.
47. S. Carra, J.F. Brunsting, H. Lambert, J. Landry, H.H. Kampinga, HspB8 participates in protein quality control by a non-chaperone-like mechanism that requires eIF2{alpha} phosphorylation, J. Biol. Chem. 284 (9) (2009) 5523-5532.
48. X.Z. Wang, D. Ron, Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase, Science 272 (1996) 1347-1349.
49. C. Xu, B. Bailly-Maitre, et al., Endoplasmic reticulum stress: cell life and death decisions, J. Clin. Invest. 115 (10) (2005) 2656-2664.
50. N. Mizushima, B. Levine, A.M. Cuervo, D.J. Klionsky, Autophagy fights disease through cellular self-digestion, Nature 451 (7182) (2008) 1069-1075.
51. B. Levine, G. Kroemer, Autophagy in the pathogenesis of disease, Cell 132 (1) (2008) 27-42.
52. M. Salazar, A. Carracedo, I.J. Salanueva, S. Hernández-Tiedra, M. Lorente, A. Egia, P. Vázquez, C. Blázquez, S. Torres, S. García, J. Nowak, G.M. Fimia, M. Piacentini, F. Cecconi, P.P. Pandolfi, L. González-Feria, J.L. Iovanna, M. Guzmán, P. Boya, G. Velasco, Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells, J. Clin. Invest. 119 (5) (2009) 1359-1372.
53. K.M. Livesey, D. Tang, H.J. Zeh, M.T. Lotze, Autophagy inhibition in combination cancer treatment, Curr. Opin. Invest. Drugs 10 (12) (2009) 1269-1279.
54. H. Yu, J. Su, Y. Xu, J. Kang, H. Li, L. Zhang, H. Yi, X. Xiang, F. Liu, L. Sun, p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins, Eur. J. Cancer (2011) (Epub ahead of print).
55. L. Harhaji-Trajkovic, U. Vilimanovich, T. Kravic-Stevovic, V. Bumbasirevic, V. Trajkovic, AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells, J. Cell Mol. Med. 13 (9B) (2009) 3644-3654.
56. J. Song, Z. Qu, X. Guo, Q. Zhao, X. Zhao, L. Gao, K. Sun, F. Shen, M. Wu, L. Wei, Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells, Autophagy 5 (8) (2009) 1131-1144 (Epub 2009 November 4).
57. J.H. Ren, W.S. He, L. Nong, Q.Y. Zhu, K. Hu, R.G. Zhang, L.L. Huang, F. Zhu, G. Wu, Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy, Cancer Biother. Radiopharm. 25 (1) (2010) 75-80.
58. C.A. Rabik, M.L. Fishel, J.L. Holleran, K. Kasza, M.R. Kelley, M.J. Egorin, M.E. Dolan, Enhancement of cisplatin [cis-diammine dichloroplatinum (II)] cytotoxicity by O6-benzylguanine involves endoplasmic reticulum stress, J. Pharmacol. Exp. Ther. 327 (2) (2008) 442-452 (Epub 2008 July 29).
59. M. Suzuki, M. Endo, F. Shinohara, S. Echigo, H. Rikiishi, Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells, Cancer Chemother. Pharmacol. 64 (6) (2009) 1115-1122 (Epub 2009 March 11).